We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Continues Assault on Patent Provisions in BioShield II
GPhA Continues Assault on Patent Provisions in BioShield II
May 17, 2005
Recently introduced biodefense legislation that would provide tax and patent incentives for brand firms isn’t needed to spur innovation and could actually endanger the public health, according to the Generic Pharmaceutical Association (GPhA), which last week continued its attack on the proposed legislation.